What types of cancer is Alvocidib used for?

Alvocidib is being researched for many cancers, including leukemia, kidney cancer, liver cancer, prostate cancer, and breast cancer.

How does Alvocidib work to treat cancer?

Alvocidib works by blocking several cyclin-dependent kinases (CDKs), which are proteins that help cancer cells grow and divide.

Is Alvocidib an oral medication?

The provided data does not specify if Alvocidib is taken by mouth or through other methods.

What is the current development stage of Alvocidib?

Alvocidib is currently in Phase 3 of clinical development.

Does Alvocidib target specific proteins?

Yes, Alvocidib targets several proteins known as Cyclin-dependent kinase 1, 2, 4, 6, 7, and 9.

Can Alvocidib treat lymphoma?

Yes, Alvocidib has been studied for its potential use in treating lymphoma.

alvocidib | CAS 146426-40-6 | BIIVYFLTOXDAOV

Loading compound...

Cyclin-dependent kinase inhibitor

Alvocidib is a small molecule drug that is being studied for its ability to treat several types of cancer. It works by inhibiting specific proteins called cyclin-dependent kinases, which play a role in how cells grow and divide.

How it worksAlvocidib acts as an inhibitor for various cyclin-dependent kinases (CDK 1, 2, 4, 6, 7, and 9). By blocking these proteins, the drug can interfere with the normal cycle of cell growth and division in cancer cells.

Used for

Prolymphocytic leukemiaKidney cancerLiver cancerEsophageal cancerProstate cancerEndometrial cancerAcute myeloid leukemiaCutaneous melanomaSarcomaChronic lymphocytic leukemiaLymphomaMultiple myelomaLymphoid neoplasmBreast cancer

Conditions

Prolymphocytic leukemiaKidney cancerLiver cancerEsophaeal cancerProstate cancerEndometrial cancerAcute myeloid leukemiaCutaneous melanomaSarcomaChronic lymphocytic leukemiaLymphomaMultiple myelomaLymphoid neoplasmBreast cancer

Class

CDK inhibitorSmall moleculeAntineoplasticCyclin-dependent kinase inhibitorHematologicRenalHepaticDigestiveReproductive

How to take

Alvocidib is currently in clinical development (Max Phase 3) and is not yet widely approved for standard use in all listed conditions. Specific dosing instructions are not available in the provided data.

Talk to your doctor

Questions to ask

·Is Alvocidib appropriate for my specific type of cancer?
·What are the potential risks of taking Alvocidib?
·How will Alvocidib interact with my current medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)